Acute non-ST-elevation acute coronary syndromes: Early antiplatelet therapy - UpToDate
uptodate.com · 295 words · saved by 1 readers
{{configCtrl2.info.metaDescription}}
Acute non-ST-elevation acute coronary syndromes: Initial antiplatelet therapy INTRODUCTION In patients with acute coronary syndromes (ACS), antiplatelet therapy inhibits platelet-mediated thrombosis and reduces the clinical risk of death and recurrent myocardial infarction (MI). This topic addresses the use of antiplatelet therapy in patients with acute non-ST-elevation acute coronary syndromes (NSTEACS) based on the strategy chosen for management (ie, invasive strategy, noninvasive strategy) (algorithm 1) and covers the initial approach (algorithm 2) to the type and timing of…
related reading
- Overview of the acute management of non-ST-elevation acute coronary syndromesuptodate.com
- Therapy for acute basilar artery occlusion: a systematic review and meta-analysisncbi.nlm.nih.gov
- Peripheral Arterial Disease - StatPearls - NCBI Bookshelfncbi.nlm.nih.gov
- Some Perspectives on Hypersensitivity to Coronary Stentsncbi.nlm.nih.gov
- Chronic coronary syndrome: Overview of careuptodate.com
- Atrioventricular nodal reentrant tachycardia - UpToDateuptodate.com
- Initial assessment and management of acute strokeuptodate.com
- Notionnotion.so
- Overview of the treatment of newly diagnosed, invasive, non-metastatic breast canceruptodate.com
- Acute pericarditis: Treatment and prognosisuptodate.com
- Acute pericarditis: Clinical presentation and diagnosisuptodate.com
- Antimicrobial therapy of left-sided native valve endocarditisuptodate.com